Skip to content

Biolam

Healthcare·Belgium·Exited 2022
Entry
–
Hold
–
Exit
2022

Who owns Biolam?

Biolam is a Belgian Healthcare company, now owned by Management backed by investors, which acquired it in 2022 from Gimv.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Gimv
Most recent investor
Gimv
2 ownership periods · full history below
Fund attribution unclassified.

Key facts

HQBelgium
SectorHealthcare

Ownership history

1 ownership period · 1 lender on file

Exited
Last exited in 2022 to Management backed by investors.
Andera Partners
2022 · present(4yr) · Acto Mezzanine IV · 2020 · Mezzanine
Gimv
GimvExited 2022
exited 2022 · Gimv Portfolio
Secondary · to Management backed by investors

Gimv sold Biolam to Management backed by investors in 2022.

Questions

Who owns Biolam?

Biolam is now owned by Management backed by investors, which acquired it in 2022 from Gimv.

When did Management backed by investors acquire Biolam?

Management backed by investors acquired Biolam in 2022, buying from Gimv.

Who did Biolam sell to?

Gimv sold Biolam to Management backed by investors in 2022 (Secondary).

Who has owned Biolam over time?

Biolam has been through 2 private-equity ownership periods: Andera Partners · via Acto Mezzanine IV · since 2022; Gimv · sold to Management backed by investors · (Secondary).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue